IMTX MT Newswires 6 days ago Biotech Sector Poised for Growth Driven by Trial Data, Pharma Deals, BofA Says
IMTX MT Newswires 6 days ago BofA Adjusts Price Target on Immatics to $17 From $14, Maintains Buy Rating